• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Etiology and genetic diagnosis of short stature in children].[儿童身材矮小的病因及基因诊断]
Zhongguo Dang Dai Er Ke Za Zhi. 2019 Apr;21(4):381-386. doi: 10.7499/j.issn.1008-8830.2019.04.015.
2
Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.比较重组人生长激素治疗儿童特发性身材矮小和生长激素缺乏症的疗效和安全性。
Growth Horm IGF Res. 2020 Aug-Oct;53-54:101331. doi: 10.1016/j.ghir.2020.101331. Epub 2020 Jul 17.
3
Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?患有特发性身材矮小和孤立性生长激素缺乏症的儿童在接受生长激素和促黄体生成素释放激素激动剂治疗后的生长结果是否优于单独使用生长激素所获得的结果?
J Pediatr Endocrinol Metab. 2012;25(7-8):651-7. doi: 10.1515/jpem-2012-0182.
4
Effect of growth hormone treatment on craniofacial growth in children: Idiopathic short stature versus growth hormone deficiency.生长激素治疗对儿童颅面生长的影响:特发性身材矮小与生长激素缺乏症的比较。
J Formos Med Assoc. 2017 Apr;116(4):313-321. doi: 10.1016/j.jfma.2016.05.011. Epub 2016 Jul 14.
5
Impact of different growth hormone levels on gut microbiota and metabolism in short stature.不同生长激素水平对身材矮小者肠道微生物群及代谢的影响
Pediatr Res. 2024 Jul;96(1):115-123. doi: 10.1038/s41390-024-03140-4. Epub 2024 Apr 6.
6
Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.评估生长激素治疗对矮小儿童 IGF-1 Z 评分的安全性和疗效。
Adv Ther. 2019 Sep;36(9):2374-2383. doi: 10.1007/s12325-019-01021-5. Epub 2019 Jul 12.
7
Therapeutic efficacy of recombinant human growth hormone in children with different etiologies of dwarfism from a pharmacoeconomic point of view.从药物经济学角度评价重组人生长激素治疗不同病因矮小儿童的疗效。
Medicine (Baltimore). 2024 Jun 21;103(25):e38350. doi: 10.1097/MD.0000000000038350.
8
Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.特发性身材矮小患儿与生长激素缺乏症患儿的生长激素(GH)和胰岛素样生长因子(IGF)敏感性存在不同程度的变化:基于 IGF 的剂量研究对矮小儿童的证据。
J Clin Endocrinol Metab. 2010 May;95(5):2089-98. doi: 10.1210/jc.2009-2139. Epub 2010 Mar 5.
9
Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.生长激素治疗与青春期对特发性身材矮小和生长激素缺乏症儿童骨骼及身体成分的影响。
Bone. 2005 Nov;37(5):642-50. doi: 10.1016/j.bone.2005.06.012. Epub 2005 Sep 1.
10
Skeletal and dental age discrepancy and occlusal traits in children with growth hormone deficiency and idiopathic short stature.生长激素缺乏症和特发性身材矮小儿童的骨骼和牙齿年龄差异及咬合特征。
Clin Oral Investig. 2022 Oct;26(10):6165-6175. doi: 10.1007/s00784-022-04566-y. Epub 2022 Jun 11.

引用本文的文献

1
Impact of different growth hormone levels on gut microbiota and metabolism in short stature.不同生长激素水平对身材矮小者肠道微生物群及代谢的影响
Pediatr Res. 2024 Jul;96(1):115-123. doi: 10.1038/s41390-024-03140-4. Epub 2024 Apr 6.
2
A Randomized Controlled Phase 3 Study on the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Idiopathic Short Stature.一项重组人生长激素治疗特发性身材矮小儿童的随机对照 3 期疗效和安全性研究。
Front Endocrinol (Lausanne). 2022 Apr 29;13:864908. doi: 10.3389/fendo.2022.864908. eCollection 2022.
3
Body composition in preschool children with short stature: a case-control study.矮身材学龄前儿童的身体成分:病例对照研究。
BMC Pediatr. 2022 Feb 18;22(1):98. doi: 10.1186/s12887-022-03159-8.
4
A Clinical Study on the Treatment of Children's Short Stature with Auxiliary Comprehensive Management Combined with Growth Patch.辅助综合管理联合生长贴治疗儿童矮小症的临床研究
Evid Based Complement Alternat Med. 2021 Oct 27;2021:7142006. doi: 10.1155/2021/7142006. eCollection 2021.

本文引用的文献

1
Long-term metabolic risk among children born premature or small for gestational age.早产儿或小于胎龄儿的长期代谢风险。
Nat Rev Endocrinol. 2017 Jan;13(1):50-62. doi: 10.1038/nrendo.2016.127. Epub 2016 Aug 19.
2
Comprehensive clinical approach to renal tubular acidosis.肾小管酸中毒的综合临床治疗方法。
Clin Exp Nephrol. 2015 Aug;19(4):556-61. doi: 10.1007/s10157-015-1119-x. Epub 2015 May 9.
3
Etiologies and early diagnosis of short stature and growth failure in children and adolescents.儿童和青少年身材矮小和生长障碍的病因和早期诊断。
J Pediatr. 2014 May;164(5 Suppl):S1-14.e6. doi: 10.1016/j.jpeds.2014.02.027.
4
The trisomy 18 syndrome.18 三体综合征。
Orphanet J Rare Dis. 2012 Oct 23;7:81. doi: 10.1186/1750-1172-7-81.
5
Hundreds of variants clustered in genomic loci and biological pathways affect human height.数以百计的变异体聚集在基因组位置和生物途径中,影响人类身高。
Nature. 2010 Oct 14;467(7317):832-8. doi: 10.1038/nature09410. Epub 2010 Sep 29.
6
[Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years].《中国0至18岁儿童青少年身高、体重标准化生长曲线图》
Zhonghua Er Ke Za Zhi. 2009 Jul;47(7):487-92.
7
Gonadoblastoma and Turner syndrome.性腺母细胞瘤与特纳综合征。
J Urol. 2006 May;175(5):1858-60. doi: 10.1016/S0022-5347(05)00932-8.
8
Gonadoblastoma in Turner syndrome patients with nonmosaic 45,X karyotype and Y chromosome sequences.具有非嵌合型45,X核型和Y染色体序列的特纳综合征患者中的性腺母细胞瘤。
Cancer Genet Cytogenet. 2004 Apr 1;150(1):70-2. doi: 10.1016/j.cancergencyto.2003.08.011.
9
Towards a consensus on the definition of idiopathic short stature.关于特发性身材矮小定义的共识
Horm Res. 1996;45 Suppl 2:64-6. doi: 10.1159/000184851.

[儿童身材矮小的病因及基因诊断]

[Etiology and genetic diagnosis of short stature in children].

作者信息

Chen Wei-Wei, Liu Huan-Xin, Liu Jing, Yang Lin-Lin, Liu Min, Ma Hui-Juan

机构信息

Graduate School of Hebei Medical University, Shijiazhuang 050017, China.

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2019 Apr;21(4):381-386. doi: 10.7499/j.issn.1008-8830.2019.04.015.

DOI:10.7499/j.issn.1008-8830.2019.04.015
PMID:31014433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7389227/
Abstract

OBJECTIVE

To study the etiology and genetic diagnosis of children with short stature.

METHODS

A retrospective analysis was performed to study the etiological distribution and clinical features of 86 children with short stature.

RESULTS

A total of 6 causes were observed in these children, among which idiopathic short stature (ISS, 41%) and growth hormone deficiency (GHD, 29%) were the most common causes, followed by genetic diseases (14%). There were no significant differences in age at the time of diagnosis, body height, body length and weight at birth, body height of parents and insulin-like growth factor-1 levels between the genetic disease group and the ISS/GHD groups (P>0.05). Compared with the ISS group, the genetic disease group had significantly lower deviation from the 3rd percentile for the height of children of the same age and sex (ΔP3) and height standard deviation score (P<0.05), while there were no significant differences between the genetic disease and GHD groups (P>0.05). The analysis of the clinical manifestations for the genetic disease group showed heterogeneity and phenotypic overlap in children with different genetic diseases.

CONCLUSIONS

ISS, GHD and genetic diseases are major causes of short stature in children. For children with severe short stature, genetic testing should be performed to make a definitive diagnosis after GHD has been excluded.

摘要

目的

研究身材矮小儿童的病因及基因诊断。

方法

对86例身材矮小儿童的病因分布及临床特征进行回顾性分析。

结果

这些儿童共观察到6种病因,其中特发性身材矮小(ISS,41%)和生长激素缺乏症(GHD,29%)是最常见的病因,其次是遗传疾病(14%)。遗传疾病组与ISS/GHD组在诊断时的年龄、出生时的身高、身长和体重、父母身高以及胰岛素样生长因子-1水平方面无显著差异(P>0.05)。与ISS组相比,遗传疾病组同年龄、同性别的儿童身高低于第3百分位数的差值(ΔP3)和身高标准差评分显著更低(P<0.05),而遗传疾病组与GHD组之间无显著差异(P>0.05)。遗传疾病组的临床表现分析显示,不同遗传疾病患儿存在异质性和表型重叠。

结论

ISS、GHD和遗传疾病是儿童身材矮小的主要原因。对于严重身材矮小的儿童,应在排除GHD后进行基因检测以明确诊断。